New Key Statistics Module, Z-Score and F-Score
OTCPK:BLCM Key Ratios
| Market Cap $ M | 0.73 |
| Enterprise Value $ M | -45.43 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.72 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 26.40 |
| 5-y EBITDA Growth Rate % | 54.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.91 |
| EV-to-EBITDA | 1.91 |
| PEG | -- |
| Shares Outstanding M | 9.72 |
| Net Margin (%) | -1,483.95 |
| Operating Margin % | -1,579.97 |
| Pre-tax Margin (%) | -1,483.82 |
| Quick Ratio | 3.04 |
| Current Ratio | 3.04 |
| ROA % (ttm) | -127.22 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -2,891.50 |
| Dividend Yield % | -- |
| Altman Z-Score | -130.60 |
| Piotroski F-Score | 2.00 |
| Positive ROA | N |
| Positive CFROA | N |
| Higher ROA y-y | Y |
| Cash flow > Earnings | N |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
BLCM Number of Guru Trades
BLCM Volume of Guru Trades
Gurus Latest Trades with OTCPK:BLCM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:BLCM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bellicum Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:BLCM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers